Nivolumab,Ipilimumab
BMS
[]
 does that correlate with any long term measure or how was the 10% chosen?
Associate Professor, Ass. Director CTO & Director early therapy research heme @Yale. I tweet on cancer, travel & food. Personal views.COI: https://t.co/6XkF8CE4ji